News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries and for story ideas.
MSK received top rankings in gynecology, urology, and several subspecialties
For more than 137 years, MSK has made historic contributions driving discovery and improving patient care. Take a look back at the progress we've made since the signing of the National Cancer Act in 1971.
In the News
Three faculty members from Memorial Sloan Kettering Cancer Center (MSK) and Sloan Kettering Institute (SKI) have been elected to the 2021 class of American Association for the Advancement of Science (AAAS) Fellows.
Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State’s 2022 Health Care Power 100 list.
Learn about some of the most important clinical advances made at MSK in 2021.
Stay Connected with MSK
News Releases
Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology.
Longtime donors Fiona and Stanley Druckenmiller have contributed a transformative gift of $100 million to MSK through their foundation. The gift will be used to launch the Fiona and Stanley Druckenmiller Presidential Innovation Fund.
Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center.
Media Coverage
Here’s what some physicians and public-health experts say about how to approach testing for Covid-19. MSK’s Esther Babady is quoted. Note: this article is behind a paywall.
Thursday, January 27, 2022
MSKs Craig Thompson is featured on this year’s City & State NY Health Care Power 100 list which highlights public health officials, hospital executives, labor leaders, activists and other influential figures that have shaped New York’s response to the pandemic – and other pressing health care matters – over the past year.
Tuesday, January 25, 2022
MSK’s Ushma Neill co-authored an op-ed highlighting a potential solution that is readily available to help alleviate some of the current shortage: removing the archaic, discriminatory and unscientific US Food and Drug Administration restrictions underlying blood donation from men who have sex with men.
Friday, January 21, 2022
News from the Lab
Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
Could an implantable IUD help detect cancer early, when it is most curable? Scientists at the Sloan Kettering Institute are betting yes.
Meet Zhongmin Wang, a fifth-year doctoral student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), who has been awarded the 2021 Chairman’s Prize.
MSK News
Doctors and scientists at MSK are desperately trying to figure out why more young patients like Rebecca, 33, are getting colorectal cancer — and how best to treat them.
Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Discover how cyclist Stacia Smart turned her grief into purpose after her boyfriend died of a brain tumor.
2020 Annual Report: Meeting the Moment
MSK researchers like physician-scientist Karuna Ganesh are using an innovative technology called organoids to unlock the mysteries of cancer metastasis.
In her new role as Chief Health Equity Officer, gynecologic cancer surgeon Carol Brown is leading a new commitment to reducing cancer disparities. Dr. Brown spoke with NBC’s Today show anchor Al Roker about raising awareness about these disparities.
Memorial Sloan Kettering staff, patients, and donors stepped up in extraordinary ways during the COVID-19 pandemic. Meet just some of these heroes.